Hyun Jin Kim

No ORCID on file · 5 papers in corpus · active 2013-2022

Study types

  • article 5

Condition tags

  • endometriosis 4
  • infertility 1
  • endometrioma 1
article 2022
Dienogest May Reduce Estradiol- and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture- and Mouse Model-Based Study
Biomedicines ·doi:10.3390/biomedicines10112992

Dienogest (DNG) is a therapeutic medication used in endometriosis treatment. Limited data are available regarding its mechanism of action on endometrial cells. Using in vivo and in vitro models, we investigated whether DNG treatment causes …

article 2020
Plasma levels of polychlorinated biphenyl, genetic polymorphisms, and the risk of advanced stage endometriosis
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2020.1753183

Both environmental and genetic factors interact and play a critical role in the pathogenesis of endometriosis. We analyzed the plasma levels of 12 polychlorinated biphenyl (PCB) congeners with genetic polymorphisms of glutathione-S-transfer…

article 2019
Effects of dienogest on breast : MCF cell line data
·doi:10.1016/j.fertnstert.2019.07.926
article 2019
Endometriosis and infertility
·doi:10.5124/jkma.2019.62.10.519

Endometriosis is a chronic inflammatory disease that affects 10% to 15% of all women of reproductive age. Several studies show an association between endometriosis and infertility; however, clear causality remains unproven. The association …

article 2013
Differential induction of autophagy by mTOR is associated with abnormal apoptosis in ovarian endometriotic cysts
Molecular human reproduction ·doi:10.1093/molehr/gat091

Mammalian target of rapamycin (mTOR) is known to be a major negative regulator of autophagy. Recent studies have shown that mTOR activity is abnormally increased in endometriotic lesions. In endometriosis, abnormal mTOR activity may contrib…